Association between glycosylated hemoglobin and blood lead: A cross-sectional study. [PDF]
Wang W +6 more
europepmc +1 more source
Iron Deficiency Anemia- Does it affect the Glycosylated Hemoglobin levels in Non- diabetic Patients?
Surya D. Aggarwal +3 more
openalex +1 more source
Association of contrast sensitivity with LogMAR visual acuity and glycosylated hemoglobin in non-insulin dependent diabetes mellitus [PDF]
Shaili Misra +5 more
openalex +1 more source
ABSTRACT Ramadan fasting involves prolonged daily abstinence from food and water and may affect blood pressure (BP) regulation, particularly in individuals with chronic conditions. Evidence focusing specifically on ambulatory BP characteristics during Ramadan remains limited.
Mustafa Celik +6 more
wiley +1 more source
Corrigendum to "Improvements in glycosylated hemoglobin A1c and blood pressure as measured through electronic health records across four produce prescription projects in the northeastern and Western United States" [Prevent. Med. Rep. 62 (2026) 103394]. [PDF]
Zigmont VA +8 more
europepmc +1 more source
Usefulness of glycated albumin level as a glycemic index complementing glycosylated hemoglobin in diabetic children and adolescents. [PDF]
Choi YJ +7 more
europepmc +1 more source
Serial Glycosylated Hemoglobin Levels and Risk of Colorectal Neoplasia among Patients with Type 2 Diabetes Mellitus [PDF]
Yu‐Xiao Yang +7 more
openalex +1 more source
Serum levels of CTRP3 and CysC in elderly patients with T2DM and OP are closely associated with glucose‐lipid metabolism, bone mineral density, and bone metabolism markers. Combined detection of these two markers can assist in distinguishing OP in elderly patients with T2DM.
Yi‐Peng Wang +4 more
wiley +1 more source
Relationship Between Glycosylated Hemoglobin and Serum Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Analysis. [PDF]
Uddin MF +10 more
europepmc +1 more source
ABSTRACT Introduction Diabetic neuropathy, the most common long‐term complication of diabetes, frequently presents as painful diabetic peripheral neuropathy (pDPN), significantly impairing patients' quality of life. Pregabalin is an established treatment for pDPN, but optimal dosing and the influence of glycemic control on efficacy remain uncertain ...
Ashish Bajaj +6 more
wiley +1 more source

